Delving into Longevity with Centuries-Old Blood Tests

Insights into longevity provided by analyzing blood samples from centenarians.

May 2024

Centenarians , once considered rare, have become commonplace . In fact, they are the fastest growing demographic of the world’s population, with numbers approximately doubling every ten years since the 1970s.

Blood biomarker profiles and exceptional longevity: comparison of centenarians and non-centenarians in a 35-year follow-up of the Swedish AMORIS cohort

Summary

Comparison of biomarker profiles measured at similar ages, but earlier in life, between exceptionally long-lived individuals and their shorter-lived peers may improve our understanding of aging processes. This study aimed to (i) describe and compare biomarker profiles at similar ages between 64 and 99 years between individuals who will eventually become centenarians and their shorter-lived peers, (ii) investigate the association between specific biomarker values ​​and the probability of reaching age 100, and (iii) examine the extent to which centenarians have homogeneous biomarker profiles earlier in life.

Participants in the AMORIS population-based cohort with information on blood biomarkers measured during 1985-1996 were followed in Swedish registry data for up to 35 years. We examined biomarkers of metabolism, inflammation, liver, kidney, anemia, and nutritional status using descriptive statistics, logistic regression, and cluster analysis. In total, 1,224 participants (84.6% women) lived to be 100 years old.

Higher levels of total cholesterol and iron and lower levels of glucose, creatinine, uric acid, aspartate aminotransferase, gamma-glutamyl transferase, alkaline phosphatase, lactate dehydrogenase, and total iron-binding capacity were associated with reaching age 100 years. In general, centenarians showed fairly homogeneous biomarker profiles. Already at age 65 and older, centenarians showed more favorable biomarker values ​​in commonly available biomarkers than individuals who died before age 100.

Source : Murata, S., Ebeling, M., Meyer, AC et al. Blood biomarker profiles and exceptional longevity: comparison of centenarians and non-centenarians in a 35-year follow-up of the Swedish AMORIS cohort. GeroScience (2023). https://doi.org/10.1007/s11357-023-00936-w

Delving into Longevity with Centuries-Old Blood Te
Figure : Quantiles (10, 25, 50, 75, 90) of biomarkers for centenarians and non-centenarians. Green areas show the normal range of each biomarker based on commonly used clinical thresholds (see Supplementary Table 1 for details). Multiple imputed data were used and 44,636 participants were included. TC: total cholesterol; ALAT, alanine aminotransferase; ASAT, aspartate aminotransferase; GGT, gamma-glutamyl transferase; ALP, alkaline phosphatase; TIBC, total iron binding capacity. 

Comments

How long humans can live and what determines a long, healthy life have been of interest for as long as we know. Plato and Aristotle discussed and wrote about the aging process more than 2,300 years ago.

However, the quest to understand the secrets behind exceptional longevity is not easy. It involves unraveling the complex interplay of genetic predisposition and lifestyle factors and how they interact throughout a person’s life. Now, our recent study, published in GeroScience , has revealed some common biomarkers, including cholesterol and glucose levels , in people living beyond 90 years.

Nonagenarians and centenarians have long been of great interest to scientists, as they can help us understand how to live longer and perhaps also how to age in better health. Until now, studies on centenarians have often been small-scale and focused on a selected group, excluding, for example, centenarians living in nursing homes.

Huge data set

Ours is the largest study comparing biomarker profiles measured across the lifespan between exceptionally long-lived people and their shorter-lived peers to date.

We compared the biomarker profiles of people who lived to be over 100 years old and their shorter-lived peers, and investigated the link between the profiles and the chance of becoming a centenarian.

Our research included data from 44,000 Swedes who underwent health assessments between ages 64 and 99; They were a sample of the so-called Amoris cohort. These participants were then followed through Swedish registry data for up to 35 years. Of these people, 1,224, or 2.7%, lived to be 100 years old. The vast majority (85%) of centenarians were women .

Twelve blood biomarkers related to inflammation, metabolism, liver and kidney function, as well as possible malnutrition and anemia were included . All of these have been associated with aging or mortality in previous studies.

The biomarker linked to inflammation was uric acid , a body waste product caused by the digestion of certain foods. We also analyzed markers related to metabolic status and function , including total cholesterol and glucose, and those related to liver function, such as alanine aminotransferase (Alat), aspartate aminotransferase (Asat), albumin, gamma-glutamyl transferase (GGT), alkaline phosphatase. (Alp) and lactate dehydrogenase (LD).

We also looked at creatinine, which is related to kidney function, and iron and total iron binding capacity (TIBC), which is related to anemia. Finally, we also investigated albumin, a biomarker associated with nutrition.

Results

We found that, in general, those who lived to be one hundred years old tended to have lower levels of glucose, creatinine, and uric acid starting at age sixty. Although median values ​​did not differ significantly between centenarians and non-centenarians for most biomarkers, centenarians rarely showed extremely high or low values.

For example, very few centenarians had a glucose level above 6.5 earlier in their life, or a creatinine level above 125.

For many of the biomarkers, both centenarians and non-centenarians had values ​​outside the range considered normal in clinical guidelines. This is probably because these guidelines are set based on a younger, healthier population.

When exploring which biomarkers were related to the probability of turning 100, we found that all but two (alat and albumin) of the 12 biomarkers showed a connection with the probability of turning 100. This was even after taking into account age, sex and disease burden. .

People in the lowest levels of five total cholesterol and iron groups were less likely to reach age 100 compared to those with higher levels. Meanwhile, people with higher levels of glucose, creatinine, uric acid and markers of liver function also decreased their chances of becoming centenarians.

In absolute terms, the differences were quite small for some of the biomarkers, while for others the differences were somewhat more substantial.

In the case of uric acid , for example, the absolute difference was 2.5 percentage points. This means that people in the group with the lowest uric acid level had a 4% chance of turning 100, while in the group with the highest uric acid levels only 1.5% reached 100. years.

Even if the differences we discovered were overall quite small, they suggest a potential link between metabolic health, nutrition, and exceptional longevity .

However, the study does not allow conclusions to be drawn about which lifestyle factors or genes are responsible for the biomarker values. However, it is reasonable to think that factors such as nutrition and alcohol intake play a role. It’s probably not a bad idea to track kidney and liver values, as well as glucose and uric acid as we age.

That said, chance is likely to play a role in reaching an exceptional age at some point. But the fact that differences in biomarkers could be seen long before death suggests that genes and lifestyle may also play a role.

Source : Centenarian blood tests give hints of the secrets to longevity. The Conversation

Conclusions

In conclusion, starting at age 65 , a difference in commonly available biomarkers was observed between individuals who eventually became centenarians and those who did not. Higher levels of total cholesterol and iron and lower levels of glucose, creatinine, uric acid, ASAT, GGT, ALP, TIBC, and LD were associated with a higher likelihood of becoming a centenarian. While chance is likely to influence achievement of 100 years, differences in biomarker values ​​more than a decade before death suggest that genetic and/or lifestyle factors, reflected in these levels of biomarkers, may also play a role in exceptional longevity. Our work, to date the largest study on this topic, also shows that centenarians had homogeneous biomarker profiles, underscoring the importance of specific biomarker characteristics in exceptional longevity research.